Krüppel-Like factor 6, is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells

Cancer Research

Volumn 64, Issue 11, 2004, Pages 3838-3843

  Ito, Genshi ^a   Uchiyama, Mika ^a   Kondo, Masashi ^a   Mori, Shoichi ^a   Usami, Noriyasu ^a   Maeda, Osamu ^a   Kawabe, Tsutomu ^a   Hasegawa, Yoshinori ^a   Shimokata, Kaoru ^a   Sekido, Yoshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 6; LIPOCORTIN 5; PROTEIN KLF6; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ALLELIC EXCLUSION; APOPTOSIS; ARTICLE; ASTROCYTOMA; CHROMOSOME 10P; COLONY FORMATION; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCUS; GENETIC TRANSFECTION; GLIOMA; GROWTH INHIBITION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KLF6 GENE; LASER CAPTURE MICRODISSECTION; LUNG NON SMALL CELL CANCER; METHYLATION; NICK END LABELING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN ANALYSIS; RNA ANALYSIS; SOMATIC MUTATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WAF1 GENE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 10; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 2542521484     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0185     Document Type: Article

References (33)

1. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med 2003;54:73-87.
2. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997;57:2331-5.
3. Schwendel A, Langreck H, Reichel M, et al. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer 1997;74:86-93.
4. Michelland S, Gazzeri S, Brambilla E, Robert-Nicoud M. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet Cytogenet 1999;114:22-30.
5. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000;18:1001-5.
6. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-83.
7. Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-906.
8. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143-60.
9. Dang DT, Bachman KE, Mahatan CS, Dang LH, Giardiello FM, Yang VW. Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett 2000;476:203-7.
10. Chen C, Bhalala HV, Qiao H, Dong JT. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 2002;21:6567-72.
11. Subramaniam M, Hefferan TE, Tau K, et al. Tissue, cell type, and breast cancer stage-specific expression of a TGF-β inducible early transcription factor gene. J Cell Biochem 1998;68:226-36.
12. Narla G, Heath KE, Reeves HL, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001;294:2563-6.
13. Wikman H, Kettunen E, Seppanen JK, et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002;21:5804-13.
14. Sekido Y, Sato M, Usami N, et al. Establishment of a large cell lung cancer cell line (Y-ML-1B) producing granulocyte colony-stimulating factor. Cancer Genet Cytogenet 2002;137:33-42.
15. Uchiyama M, Usami N, Kondo M, et al. Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer. Int J Cancer 2003;107:962-9.
16. Sato M, Sekido Y, Horio Y, et al. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn J Cancer Res 2000;91:504-9.
17. Shigemitsu K, Sekido Y, Usami N, et al. Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene 2001;20:4249-57.
18. Usami N, Sekido Y, Maeda O, et al. β-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion. Oncogene 2003;22:7922-30.
19. Sekido Y, Bader SA, Carbone DP, Johnson BE, Minna JD. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res 1994;54:4988-92.
20. Mori S, Ito G, Usami N, et al. P53 apoptotic pathway molecules are frequently and simultaneously altered in non-small cell lung cancer. Cancer 2004;100:1673-82.
21. Vax VV, Gueorguiev M, Dedov II, Grossman AB, Korbonits M. The Krüppel-like transcription factor 6 gene in sporadic pituitary tumours. Endocr Relat Cancer 2003;10:397-402.
22. Jeng YM, Hsu HC. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 2003;105:625-9.
23. Chen C, Hyytinen ER, Sun X, et al. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 2003;162:1349-54.
24. Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002;2:485-95.
25. Chen JY, Funk WD, Wright WE, Shay JW, Minna JD. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene 1993;8:2159-66.
26. Ohnishi S, Ohnami S, Laub F, et al. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 2003;308:251-6.
27. Tachibana I, Imoto M, Adjei PN, et al. Overexpression of the TGF-β-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells J Clin Invest 1997;99:2365-74.
28. Kim Y, Ratziu V, Choi SG, et al. Transcriptional activation of transforming growth factor β1 and its receptors by the Krüppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998;273:33750-8.
29. Blanchon L, Bocco JL, Gallot D, et al. Co-localization of KLF6 and KLF4 with pregnancy-specific glycoproteins during human placenta development. Mech Dev 2001;105:185-9.
30. Ratziu V, Lalazar A, Wong L, et al. Zf9, a Krüppel-like transcription factor upregulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA 1998;95:9500-5.
31. Kojima S, Hayashi S, Shimokado K, et al. Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells. Blood 2000;95:1309-16.
32. Warke VG, Nambiar MP, Krishnan S, et al. Transcriptional activation of the human inducible nitric oxide synthase (iNOS) promoter by Krüppel-like factor 6. J Biol Chem 2003;16:16.
33. Chiambaretta F, Blanchon L, Rabier B, Kao WW, Liu JJ, Dastugue B, Rigal D, Sapin V. Regulation of corneal keratin-12 gene expression by the human Krüppel-like transcription factor 6. Invest Ophthalmol Vis Sci 2002;43:3422-9.